Martin Hahne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Martin Hahne has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Cindy Strehl
Department of Rheumatology and Clinical Immunology, Charité–Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany
1 shared publication F. Buttgereit
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité – Universitätsmedizin Berlin, Berlin, Deutschland
1 shared publication- Frank Buttgereit
Medizinische Klinik m. S. Rheumatologie und Klinische Immunologie, Charité – Universitätsmedizin Berlin, Gliedkörperschaft der Freien Universität Berlin und Humboldt-Universität zu Berlin , Berlin
1 shared publication - Gerd Ruediger Burmester
Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany
1 shared publication - Max Löhning
German Rheumatology Research Center (DRFZ), a Leibniz Institute, Pitzer Laboratory of Osteoarthritis Research, Berlin, Germany
1 shared publication - Monique Fangradt
Department of Rheumatology and Clinical Immunology, Charité University Hospital, Charitéplatz 1, Berlin, 10117 Germany
1 shared publication
Latest Publications
- Open Access
- 7 August 2012
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 14 (4) , R181
Human monocytes and macrophages differ in their mechanisms of adaptation to hypoxia
Introduction: Inflammatory arthritis is a progressive disease with chronic inflammation of joints, which is mainly characterized by the infiltration of immune cells and synovial hyperproliferation. Monocytes migrate towards inflamed areas and differentiate into macrophages. In inflamed tissues, much lower oxygen levels (hypoxia) are present in comparison to the peripheral blood. Hence, a metabolic adaptation process must take place. Other studies suggest that Hypoxia Inducible Factor 1-alpha (HIF-1α) may regulate this process, but the mechanism involved for human monocytes is not yet clear. To address this issue, we analyzed the expression and function of HIF-1α in monocytes and macrophages, but also considered alternative pathways involving nuclear factor of kappa light polypeptide gene enhancer in B-cells (NFκB). Methods: Isolated human CD14+ monocytes were incubated under normoxia and hypoxia conditions with or without phorbol 12-myristate 13-acetate (PMA) stimulation, respectively. Nuclear and cytosolic fractions were prepared in order to detect HIF-1α and NFκB by immunoblot. For the experiments with macrophages, primary human monocytes were differentiated into human monocyte derived macrophages (hMDM) using human macrophage colony-stimulating factor (hM-CSF). The effects of normoxia and hypoxia on gene expression were compared between monocytes and hMDMs using quantitative PCR (quantitative polymerase chain reaction). Results: We demonstrate, using primary human monocytes and hMDM, that the localization of transcription factor HIF-1α during the differentiation process is shifted from the cytosol (in monocytes) into the nucleus (in macrophages), apparently as an adaptation to a low oxygen environment. For this localization change, protein kinase C alpha/beta 1 (PKC-α/β1 ) plays an important role. In monocytes, it is NFκB1, and not HIF-1α, which is of central importance for the expression of hypoxia-adjusted genes. Conclusions: These data demonstrate that during differentiation of monocytes into macrophages, crucial cellular adaptation mechanisms are decisively changed.
- 7 August 2012
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 14 (4) , R181
Open AccessHuman monocytes and macrophages differ in their mechanisms of adaptation to hypoxia
Introduction: Inflammatory arthritis is a progressive disease with chronic inflammation of joints, which is mainly characterized by the infiltration of immune cells and synovial hyperproliferation. Monocytes migrate towards inflamed areas and differentiate into macrophages. In inflamed tissues, much lower oxygen levels (hypoxia) are present in comparison to the peripheral blood. Hence, a metabolic adaptation process must take place. Other studies suggest that Hypoxia Inducible Factor 1-alpha (HIF-1α) may regulate this process, but the mechanism involved for human monocytes is not yet clear. To address this issue, we analyzed the expression and function of HIF-1α in monocytes and macrophages, but also considered alternative pathways involving nuclear factor of kappa light polypeptide gene enhancer in B-cells (NFκB). Methods: Isolated human CD14+ monocytes were incubated under normoxia and hypoxia conditions with or without phorbol 12-myristate 13-acetate (PMA) stimulation, respectively. Nuclear and cytosolic fractions were prepared in order to detect HIF-1α and NFκB by immunoblot. For the experiments with macrophages, primary human monocytes were differentiated into human monocyte derived macrophages (hMDM) using human macrophage colony-stimulating factor (hM-CSF). The effects of normoxia and hypoxia on gene expression were compared between monocytes and hMDMs using quantitative PCR (quantitative polymerase chain reaction). Results: We demonstrate, using primary human monocytes and hMDM, that the localization of transcription factor HIF-1α during the differentiation process is shifted from the cytosol (in monocytes) into the nucleus (in macrophages), apparently as an adaptation to a low oxygen environment. For this localization change, protein kinase C alpha/beta 1 (PKC-α/β1 ) plays an important role. In monocytes, it is NFκB1, and not HIF-1α, which is of central importance for the expression of hypoxia-adjusted genes. Conclusions: These data demonstrate that during differentiation of monocytes into macrophages, crucial cellular adaptation mechanisms are decisively changed.
- 7 December 2011
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 71 (1) , 64-67
Hypoxie als ein Schlüsselfaktor im Entzündungsgebiet bei rheumatischen Erkrankungen
Zusammenfassung Chronisch-entzündliche Erkrankungen sind charakterisiert durch das Auftreten von Sauerstoffmangel (Hypoxie) und die dadurch bedingte/notwendige zelluläre Adaptation über den hypoxieinduzierbaren Faktor (HIF). Die Modulation dieser Adaptationsmechanismen bildet die Basis für Ideen zur Wirkungsverbesserung bekannter Medikamente und für die Entwicklung neuer therapeutischer Ansatzpunkte.
- 7 December 2011
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 71 (1) , 64-67
Hypoxie als ein Schlüsselfaktor im Entzündungsgebiet bei rheumatischen Erkrankungen
Zusammenfassung Chronisch-entzündliche Erkrankungen sind charakterisiert durch das Auftreten von Sauerstoffmangel (Hypoxie) und die dadurch bedingte/notwendige zelluläre Adaptation über den hypoxieinduzierbaren Faktor (HIF). Die Modulation dieser Adaptationsmechanismen bildet die Basis für Ideen zur Wirkungsverbesserung bekannter Medikamente und für die Entwicklung neuer therapeutischer Ansatzpunkte.